7-Eleven, the iconic convenience store chain, has made a surprising entry into the world of beauty with the launch of its first-ever beauty product: a high-quality coffee body scrub. Priced at just $1, this innovative and affordable product is set to excite coffee lovers across Australia.
The 7-Eleven Coffee Body Scrub is a limited-edition product made from the same aromatic Arabica and Robusta beans found in the millions of cups of freshly ground coffee sold each year at 7-Eleven stores. The scrub is designed to exfoliate dead skin, increase blood flow, and promote healthier-looking skin. It is produced locally in Australia and is 100% naturally derived, vegan, and cruelty-free.
This exciting new product was launched on 21st March 2022 and is available exclusively via online retailer Adore Beauty from 22nd March 2022, while stocks last. Each 60-gram tub of the scrub costs only $1, making it an incredibly affordable option for those looking to indulge in a luxurious coffee-infused skincare experience.
Australian actor Olympia Valance has been chosen as the face of the new product, expressing her excitement about the combination of coffee and skincare. She said, “Coffee and skincare products are two things I can’t live without, so being the face of 7-Eleven’s Coffee Body Scrub was a no brainer.
Now I can exfoliate, rejuvenate and caffeinate with the same great coffee Australians have been enjoying for years.” 7-Eleven‘s Head of Marketing Communications, Adam Jacka, shared his enthusiasm for the launch, stating that the Coffee Body Scrub is a fun and innovative way to showcase the quality of coffee that Australians enjoy every day.
He added, “We take great pride in sourcing great quality beans from across the world to provide great coffee to customers every day.” With its unique blend of affordability and quality, the 7-Eleven Coffee Body Scrub is set to make waves in the beauty industry.
Don’t miss out on the chance to try this innovative product – head over to Adore Beauty and grab your tub of coffee scrub today!
Discussion
0 Comments
No comments yet.
Sign in to join the discussion.